MarketPulse

stock delisting risk

2 articles
BenzingaBenzinga··Prnewswire

Scinai Immunotherapeutics Faces Nasdaq Delisting Risk After Price Breach

$SCNI warned by Nasdaq for trading below $1.00 for 30 consecutive days. Company has 180 days to restore compliance or face delisting.
SCNIimmunotherapyminimum bid price requirement
GlobeNewswire Inc.GlobeNewswire Inc.··Inflarx N.V.

InflaRx Faces Nasdaq Delisting Risk After Stock Falls Below $1 Threshold

$IFRX received Nasdaq deficiency notice for failing $1 minimum bid price for 30 consecutive days. Company has until September 2026 to regain compliance or face delisting.
IFRXbiopharmaceuticalNasdaq listing compliance